BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36573458)

  • 41. LncRNA HAND2-AS1 inhibits 5-fluorouracil resistance by modulating miR-20a/PDCD4 axis in colorectal cancer.
    Jiang Z; Li L; Hou Z; Liu W; Wang H; Zhou T; Li Y; Chen S
    Cell Signal; 2020 Feb; 66():109483. PubMed ID: 31760170
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cyclopamine blocked the growth of colorectal cancer SW116 cells by modulating some target genes of Gli1 in vitro.
    Wu JY; Xu XF; Xu L; Niu PQ; Wang F; Hu GY; Wang XP; Guo CY
    Hepatogastroenterology; 2011; 58(110-111):1511-8. PubMed ID: 21940310
    [TBL] [Abstract][Full Text] [Related]  

  • 43. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
    Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y
    Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
    He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
    Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Hedgehog signaling pathway promotes chemotherapy resistance via multidrug resistance protein 1 in ovarian cancer.
    Zhang H; Hu L; Cheng M; Wang Q; Hu X; Chen Q
    Oncol Rep; 2020 Dec; 44(6):2610-2620. PubMed ID: 33125122
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patrinia scabiosaefolia Inhibits Growth of 5-FU-Resistant Colorectal Carcinoma Cells via Induction of Apoptosis and Suppression of AKT Pathway.
    Huang SZ; Liu WY; Huang Y; Shen AL; Liu LY; Peng J
    Chin J Integr Med; 2019 Feb; 25(2):116-121. PubMed ID: 29948597
    [TBL] [Abstract][Full Text] [Related]  

  • 47. miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4.
    Azar MRMH; Aghazadeh H; Mohammed HN; Sara MRS; Hosseini A; Shomali N; Tamjidifar R; Tarzi S; Mansouri M; Sarand SP; Marofi F; Akbari M; Xu H; Shotorbani SS
    Int Immunopharmacol; 2021 Mar; 92():107355. PubMed ID: 33429333
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ursolic acid inhibits the activation of smoothened-independent non-canonical hedgehog pathway in colorectal cancer by suppressing AKT signaling cascade.
    Chen L; Liu M; Yang H; Ren S; Sun Q; Zhao H; Ming T; Tang S; Tao Q; Zeng S; Meng X; Xu H
    Phytother Res; 2022 Sep; 36(9):3555-3570. PubMed ID: 35708264
    [TBL] [Abstract][Full Text] [Related]  

  • 49. miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1.
    Liu H; Yin Y; Hu Y; Feng Y; Bian Z; Yao S; Li M; You Q; Huang Z
    Pathol Res Pract; 2016 Jul; 212(7):643-9. PubMed ID: 27173050
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enalapril overcomes chemoresistance and potentiates antitumor efficacy of 5-FU in colorectal cancer by suppressing proliferation, angiogenesis, and NF-κB/STAT3-regulated proteins.
    Yang Y; Ma L; Xu Y; Liu Y; Li W; Cai J; Zhang Y
    Cell Death Dis; 2020 Jun; 11(6):477. PubMed ID: 32581212
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Suppression of Nanog inhibited cell migration and increased the sensitivity of colorectal cancer cells to 5-fluorouracil.
    Khosravi N; Shahgoli VK; Amini M; Safaei S; Mokhtarzadeh A; Mansoori B; Derakhshani A; Baghbanzadeh A; Baradaran B
    Eur J Pharmacol; 2021 Mar; 894():173871. PubMed ID: 33460610
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Knockdown of REG Iα Enhances the Sensitivity to 5-Fluorouracil of Colorectal Cancer Cells via Cyclin D1/CDK4 Pathway and BAX/BCL-2 Pathways.
    Wang Y; Liu X; Liu J; Zhang T
    Cancer Biother Radiopharm; 2019 Aug; 34(6):362-370. PubMed ID: 30973271
    [No Abstract]   [Full Text] [Related]  

  • 53. 53BP1 loss induces chemoresistance of colorectal cancer cells to 5-fluorouracil by inhibiting the ATM-CHK2-P53 pathway.
    Yao J; Huang A; Zheng X; Liu T; Lin Z; Zhang S; Yang Q; Zhang T; Ma H
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):419-431. PubMed ID: 27838786
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bcl-x(L) and Myeloid cell leukaemia-1 contribute to apoptosis resistance of colorectal cancer cells.
    Schulze-Bergkamen H; Ehrenberg R; Hickmann L; Vick B; Urbanik T; Schimanski CC; Berger MR; Schad A; Weber A; Heeger S; Galle PR; Moehler M
    World J Gastroenterol; 2008 Jun; 14(24):3829-40. PubMed ID: 18609706
    [TBL] [Abstract][Full Text] [Related]  

  • 55. STAT3 regulates 5-Fu resistance in human colorectal cancer cells by promoting Mcl-1-dependent cytoprotective autophagy.
    Yue Y; Zhang Q; Wang X; Sun Z
    Cancer Sci; 2023 Jun; 114(6):2293-2305. PubMed ID: 36788743
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The long non-coding RNA HOTAIRM1 suppresses cell progression via sponging endogenous miR-17-5p/ B-cell translocation gene 3 (BTG3) axis in 5-fluorouracil resistant colorectal cancer cells.
    Ren T; Hou J; Liu C; Shan F; Xiong X; Qin A; Chen J; Ren W
    Biomed Pharmacother; 2019 Sep; 117():109171. PubMed ID: 31261026
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Voltage-gated sodium channel Na
    Sui Q; Peng J; Han K; Lin J; Zhang R; Ou Q; Qin J; Deng Y; Zhou W; Kong L; Tang J; Xiao B; Li Y; Yu L; Fang Y; Ding PR; Pan Z
    Cancer Lett; 2021 Mar; 500():119-131. PubMed ID: 33338532
    [TBL] [Abstract][Full Text] [Related]  

  • 58. FoxO3 reverses 5-fluorouracil resistance in human colorectal cancer cells by inhibiting the Nrf2/TR1 signaling pathway.
    Liu C; Zhao Y; Wang J; Yang Y; Zhang Y; Qu X; Peng S; Yao Z; Zhao S; He B; Mi Q; Zhu Y; Liu X; Zou J; Zhang X; Du Q
    Cancer Lett; 2020 Feb; 470():29-42. PubMed ID: 31811910
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
    Hong X; Yu JJ
    Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma.
    Liu C; Guo T; Sakai A; Ren S; Fukusumi T; Ando M; Sadat S; Saito Y; Califano JA
    Cancer; 2020 Feb; 126(4):737-748. PubMed ID: 31721164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.